Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid.

Diagnostic microbiology and infectious disease ·Vol. 7 ·No. 1 ·1987-05-00 ·Pages 83-7

Barry AL, Gavan TL, Jones RN, Ayers LW, Fuchs PC, Gerlach EH, Thornsberry C

Abstract

A six-laboratory collaborative study was performed in order to define quality control limits for microdilution tests with seven new beta-lactams (aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid). Four standard control strains were tested and the expected MIC limits for each of the appropriate drug-microorganism combinations were defined.

MeSH Terms

Anti-Bacterial Agents/pharmacology Aztreonam/pharmacology Cefamandole/analogs & derivatives,pharmacology Cefonicid Cefotaxime/analogs & derivatives,pharmacology Ceftazidime/pharmacology Ceftizoxime Ceftriaxone/pharmacology Cefuroxime/pharmacology Enterococcus faecalis/drug effects Escherichia coli/drug effects Imipenem Microbial Sensitivity Tests/standards Pseudomonas aeruginosa/drug effects Quality Control Thienamycins/pharmacology

Chemicals

Anti-Bacterial Agents Thienamycins Cefamandole Cefonicid Imipenem Ceftriaxone Ceftazidime Ceftizoxime Aztreonam Cefotaxime Cefuroxime

Authors & Affiliations

7 authors, click to expand affiliations / ORCID

Barry A L

Clinical Microbiology Institute, Tualatin, OR 97062.

Gavan T L

Jones R N

Ayers L W

Fuchs P C

Gerlach E H

Thornsberry C

Article Info

Journal

Diagnostic microbiology and infectious disease

Abbr.

Diagn Microbiol Infect Dis

ISSN

0732-8893

DOI

10.1016/0732-8893(87)90076-9

Published

1987-05-00

Pages

83-7

Language

English

Region

United States

NLM ID

8305899

Subset

External Links

PubMed source DOI: 10.1016/0732-8893(87)90076-9 View journal details

Analysis Services

Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid.

Contact

WeChat Official Account